Brief: Xenetic Biosciences - Announces Publication Of Data From Partner Takeda's Phase 1/2 Study

Xenetic Biosciences

14/01/2020 13:57

Jan 14 (Reuters) - Takeda Pharmaceutical Co Ltd  4502.T :
    * XENETIC BIOSCIENCES - ANNOUNCES PUBLICATION OF DATA FROM
PARTNER
TAKEDA'S PHASE 1/2 STUDY EVALUATING PROGRAM LEVERAGING
POLYXEN(R) PLATFORM TECHNOLOGY

Source text: (http://bit.ly/30lpL2L)
Further company coverage:  4502.T 

 ((Reuters.Briefs@thomsonreuters.com;))